Output of the European Medicines Agency policy on access to documents related to corporate documents

Size: px
Start display at page:

Download "Output of the European Medicines Agency policy on access to documents related to corporate documents"

Transcription

1 09 February 2017 EMA/183710/ Output the European Medicines Agency policy on access to s related to corporate s Introductory remarks Aim the This needs to be read in conjunction with the following s: Regulation (EC) 1049/2001 the European Parliament and the Council 30 May 2001 regarding public access to European Parliament, Council and Commission s. European Medicines Agency policy on access to s (EMA/729522/2016). This, which contains guidance for the application Regulation (EC) 1049/2001 to corporate s held by the EMA, is not legally binding. For any not listed, access will be granted or refused in accordance with the principles outlined in the European Medicines Agency policy on access to s. It should also be noted that EMA has not listed all corporate s that it holds, but rather those for which it has received more requests, as well as the main corporate s which are available on its webpage. Therefore, this should be considered as 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0) Facsimile +44 (0) Send a question via our website An agency the European Union European Medicines Agency, Reproduction is authorised provided the source is acknowledged.

2 a living which will be updated on a continuous basis taking into account further experience, as well as the legal interpretation Regulation (EC) 1049/2001 given by the European Court Justice. For s related to human and veterinary products, please refer to the Output the European Medicines Agency policy on access to s related to medicinal products for human and veterinary use (EMA/127362/2006, Rev. 1). This lists a number types which may be subject to requests for access to s. 1. Procurement related s These types have been classified according to the phase the procurement, as follows: 1.1. Documents in relation to the launch the procurement 1.2. Documents in relation to the submission and opening requests to participate 1.3. Documents in relation to the submission and opening tenders 1.4. Documents in relation to the evaluation tenders 1.5. Documents in relation to the award and signature contract or cancellation It should be noted that access to s and/or information concerning procurement s made by specific parties (candidates and/or tenderers) in the at different stages is regulated by the EMA Financial Regulation, making reference to Title V Financial Regulation (EU, Euratom) 966/2012 and Delegated Regulation (EU) 1268/2012. This refers to the general right access to s made under Regulation (EC) 1049/ Conflicts interest declarations 3. SOPs and WINs 4. Corporate s available on the EMA s website EMA/127362/2006 Page 2/15

3 Abbreviations CCI Commercial confidential information PPD Protection personal data R Releasable n-r n-releasable EMA/127362/2006 Page 3/15

4 Procurement Launch the procurement 39. Pre-information notice (PIN) Published on EMA website Yes t applicable t applicable 40. Justification for using a negotiated n-r before the is launched Art st t applicable 41. R after the is launched Yes t applicable t applicable Yes (PPD) 42. Contract notice Published on EMA website Yes t applicable t applicable Submission and opening requests to participate 44. List candidates who submitted a request to n-r until the deadline Art st Art (a) t applicable participate in a restricted or for receipt for tenders has competitive with negotiation or elapsed or until negotiated cancellation the EMA/127362/2006 Page 4/15

5 45. R after the deadline for receipt for tenders has elapsed or until cancellation the, except for the names natural persons or names firms identifying one or more natural persons Yes t applicable t applicable Yes (PPD) 46. Requests to participate Yes n-r until contract Art st t applicable 47. R after contract signature or cancellation Yes t applicable t applicable Yes (PPD and CCI) 48. Written record the opening requests to n-r before deadline for Art st Art. 4.1 (a) t applicable participate receipt tenders has elapsed or cancellation the EMA/127362/2006 Page 5/15

6 49. R after deadline for receipt tenders has elapsed or cancellation the Yes t applicable t applicable Yes (PPD) 50. Written record the evaluation requests to n-r contract Art st t applicable participate the 51. R after contract signature or cancellation Yes t applicable t applicable Yes (PPD and CCI) 52. Procurement s (notice, invitation to n-r launch Art st t applicable tender, tender specifications, terms EMA/127362/2006 Page 6/15

7 53. reference and draft contract) R after launch Yes t applicable t applicable Yes (CCI, including those cases where the exception on confidentiality Art. 153(1) the rules implementation the Financial Regulation applies) 54. Additional information, questions & answers n-r publication information or information made available to candidates or tenderers Art st Unfair treatment tenderers t applicable EMA/127362/2006 Page 7/15

8 55. R from publication or information made available to candidates or tenderers Yes t applicable t applicable Yes (CCI, including those cases where the exception on confidentiality Art. 153(1) the rules implementation the Financial Regulation applies) Submission and opening tenders 57. Received tenders Yes n-r contract signature Art st Art st indent t applicable 58. n-r after contract Art st Art. 4.1 (a) t applicable signature indent 59. Decision appointing the committees for the n-r contract Art st Art st t applicable opening and evaluation tenders indent EMA/127362/2006 Page 8/15

9 60. R after contract signature or cancellation Yes t applicable t applicable Yes (PPD, including the names the members the committee) 61. Written record the opening tenders R Yes t applicable t applicable Yes (PPD) Evaluation tenders 63. Declarations on the absence conflicts interest and confidentiality signed by the evaluators R Yes t applicable t applicable Yes (PPD, including names the members the committee) EMA/127362/2006 Page 9/15

10 64. Clarification requested from tenderers during Yes n-r contract Art st Art st t applicable evaluation and their replies indent the 65. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 66. Evaluation report a n-r contract the Art st t applicable 67. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) Award and signature contract or cancellation 69. Award decision n-r adoption the decision Art st t applicable a For tenderers, a degree privileged access right is provided for in Article 113(2) the Financial Rules applicable to the general budget the Union (Regulation (EU, EURATOM) 966/2012 the European Parliament and the Council), which are applicable to the EMA as per Article 85.1 the EMA s Financial Regulation applicable to the budget EMA adopted by the Management Board on 15 January Those requests are therefore not dealt with under the provisions the Regulation (EC) 1049/2001 on Access to Documents, but under the relevant provisions the Financial Regulation. EMA/127362/2006 Page 10/15

11 70. R after adoption the decision Yes t applicable t applicable Yes 71. tification contract award to the successful n-r contract Art st t applicable tenderer the 72. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 73. Contract and its annexes Yes n-r contract the Art st st indent t applicable 74. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 75. tifications contract award to unsuccessful n-r contract Art st t applicable tenderer the 76. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) EMA/127362/2006 Page 11/15

12 77. Decision to cancel the R from signature the decision and information to the tenderers b Yes t applicable t applicable 78. tification to tenderers cancellation R from the notification to Yes t applicable t applicable Yes (PPD) tenderers having been made 79. Award cancellation notice Published on EMA website Yes t applicable t applicable Conflict interest declarations 81. Conflict interest declaration for staff - For EMA management: Yes t applicable t applicable current published on EMA website For all other EMA staff: R 82. Conflict interest declaration for staff - previous R Yes t applicable t applicable Yes (PPD) 83. Conflict interest declaration for experts - current Published on EMA website Yes t applicable t applicable b As soon as the decision is taken it must be communicated to tenderers. EMA/127362/2006 Page 12/15

13 84. Conflict interest declaration for experts - previous R Yes t applicable t applicable Yes (PPD) 85. Conflict interest declaration for Committee and Management Board Members - current Published on EMA website Yes t applicable t applicable 86. Conflict interest declaration for Committee and Management Board Members - previous R Yes t applicable t applicable Yes (PPD) SOPs and WINs 88. SOPs and WINs current version Published on EMA website Yes t applicable t applicable 89. SOPs and WINs previous versions R Yes t applicable t applicable Corporate s available on the EMA s website 91. Annual report Published on EMA website Yes t applicable t applicable 92. Work programme Published on EMA website Yes t applicable t applicable 93. Annual Budget Published on EMA website Yes t applicable t applicable EMA/127362/2006 Page 13/15

14 94. Report on budgetary and financial management Published on EMA website Yes t applicable t applicable 95. Annual accounts Published on EMA website Yes t applicable t applicable 96. European Court Auditors final report on the annual accounts the European Medicines Agency Published on EMA website Yes t applicable t applicable 97. Agendas and minutes the Management Board Published on EMA website Yes t applicable t applicable 1 2 Refers to any the EMA produces, receives or has in its possession. Means any natural or legal person, or any entity outside the EMA, including the Member States, other EU or non-eu Institutions and Bodies, and third countries. Either Yes or to be filled in. Yes may/shall lead to a consultation exercise with the third party (cfr. policy for further details) with a view to assessing whether an exception listed in Article 4 Regulation (EC) 1049/2011 is applicable, unless it is clear that the shall or shall not be disclosed. 3 Refers to classification in one the following categories: Releasable (R) or n-releasable (n-r). In certain situations the s are published on the EMA website. If this is the case, this will be indicated. 4 Either access to be granted (Yes) or to be refused (); in case third-party consultation the granting or not access will depend on the outcome such consultation. 5 Only to be filled in if access to EMA s is refused by virtue application one the exceptions mentioned in Article 4 Regulation (EC) 1049/2001, i.e. by referring to: Article 4.1.(a) The Agency shall refuse access to a where disclosure would undermine the protection the public interest as regards public security, defence and military matters, international relations, the financial, monetary or economic policy the EU or a Member State. Article 4.1.(b) The Agency shall refuse access to a where disclosure would undermine the protection privacy and the integrity the individual, in particular in accordance with EU legislation regarding the protection personal data. EMA/127362/2006 Page 14/15

15 Article st indent The Agency shall refuse access to a where disclosure would undermine the protection commercial interests a natural or legal person, including intellectual property. Article nd indent The Agency shall refuse access to a where disclosure would undermine the protection court proceedings and legal advice. Article rd indent The Agency shall refuse access to a where disclosure would undermine the protection the purpose inspections, investigations and audits. Article st paragraph process. Access to a, produced, received or in possession the Agency shall be refused if disclosure the would seriously undermine the decision-making Article nd paragraph Access to a containing opinions for internal use as part deliberations and preliminary consultations within the Agency shall be refused even after the decision has been taken if disclosure the would seriously undermine the Agency s decision-making process. 6 7 Additional justification to be provided in order to further elaborate on the rationale for not providing access as per the reference to the exceptions mentioned in Article 4. Redaction EMA s will be carried out to remove any reference to commercial confidential information or to personal data. EMA/127362/2006 Page 15/15

Decision of the Executive Director

Decision of the Executive Director 14 July 2017 EMA/275221/2017 on a 1-year initiative for fee reductions for notifications of parallel THE EXECUTIVE DIRECTOR Having regard to Regulation (EC) No 726/2004 of the European Parliament and of

More information

Procedural advice to applicants/marketing authorisation holders on re-examination of CVMP opinions

Procedural advice to applicants/marketing authorisation holders on re-examination of CVMP opinions 9 November 2017 EMA/CVMP/321528/2017 Committee for Medicinal Products for Veterinary Use Procedural advice to applicants/marketing authorisation holders on re-examination of 1. Introduction Re-examination

More information

The European Medicines Agency Code of Good Administrative Behaviour

The European Medicines Agency Code of Good Administrative Behaviour 1 September 2013 EMA/264257/2013 Administration The European Medicines Agency Code of Good Administrative Behaviour... 3 1. Scope... 3 2. Lawfulness... 3 3. Absence of discrimination... 4 4. Proportionality...

More information

Questions and Answers (Q&As) on the External Guidance of Policy 0070 on Clinical Data Publication (CDP)

Questions and Answers (Q&As) on the External Guidance of Policy 0070 on Clinical Data Publication (CDP) 20 September 2017 EMA/14227/2017 Rev. 1 Documents Access and Publication Service Office of the Deputy Executive Director Questions and Answers (Q&As) on the External Guidance of Policy 0070 on Clinical

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Annual reassessment of centrally authorised veterinary medicinal products under exceptional circumstances Status: PUBLIC Document no.: SOP/V/4006 Lead author Approver

More information

European Medicines Agency decision

European Medicines Agency decision EMA/385704/2016 European Medicines Agency decision P/0173/2016 of 17 June 2016 on the granting of a product specific waiver for ciclosporin (EMEA-001916-PIP01-15) in accordance with Regulation (EC) No

More information

European Medicines Agency decision

European Medicines Agency decision EMA/624577/2015 P/0261/2015 of 30 October 2015 on the granting of a product specific waiver for mogamulizumab (EMEA-001816-PIP02-15) in accordance with Regulation (EC) No 1901/2006 of the European Parliament

More information

European Medicines Agency decision

European Medicines Agency decision EMA/161012/2015 P/0078/2015 of 1 April 2015 on the granting of a product specific waiver for ibuprofen/codeine (EMEA-001713-PIP02-14) in accordance with Regulation (EC) No 1901/2006 of the European Parliament

More information

European Medicines Agency decision

European Medicines Agency decision EMA/666337/2017 European Medicines Agency decision P/0332/2017 of 31 October 2017 on the granting of a product specific waiver for amlodipine / irbesartan / hydrochlorothiazide (EMEA- 002167-PIP01-17)

More information

European Medicines Agency decision

European Medicines Agency decision EMA/253504/2017 European Medicines Agency decision P/0125/2017 of 5 May 2017 on the granting of a product specific waiver for ramipril / indapamide (EMEA-002081-PIP01-16) in accordance with Regulation

More information

European Medicines Agency decision

European Medicines Agency decision EMA/398292/2017 European Medicines Agency decision P/0159/2017 of 30 June 2017 on the granting of a product specific waiver for ibuprofen / pseudoephedrine (EMEA-002102-PIP01-16) in accordance with Regulation

More information

General guidance on EFSA procurements

General guidance on EFSA procurements General guidance on EFSA procurements For potential tenderers when considering the submission of a tender in response to a procurement procedure of the European Food Safety Authority Updated February 206

More information

European Medicines Agency decision

European Medicines Agency decision EMA/519145/2014 European Medicines Agency decision P/0235/2014 of 8 September 2014 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver

More information

Mandate, objectives and rules of procedure

Mandate, objectives and rules of procedure 18 February 2014 EMA/INS/GMP/414260/2013 GMP/GDP inspectors working group (GMDP IWG) 1. General considerations In 1981 the European Commission established the Working Party on Control of Medicinal Products

More information

General guidance on EFSA procurements

General guidance on EFSA procurements General guidance on EFSA procurements Important information for potential tenderers when considering the submission of a tender in response to a procurement procedure of the European Food Safety Authority

More information

European Medicines Agency decision

European Medicines Agency decision EMA/382336/2017 European Medicines Agency decision P/0177/2017 of 3 July 2017 on the granting of a product specific waiver for olmesartan medoxomil / amlodipine (besilate) / hydrochlorothiazide (EMEA-002104-PIP01-16)

More information

European Medicines Agency decision

European Medicines Agency decision EMA/87985/2018 European Medicines Agency decision P/0089/2018 of 16 March 2018 on the granting of a product specific waiver for trazodone (hydrochloride) / gabapentin (EMEA-002263- PIP01-17) in accordance

More information

European Medicines Agency decision

European Medicines Agency decision EMA/757981/2016 European Medicines Agency decision P/0341/2016 of 5 December 2016 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

European Medicines Agency decision

European Medicines Agency decision EMA/459094/2017 European Medicines Agency decision P/0215/2017 of 9 August 2017 on the granting of a product specific waiver for macitentan (Opsumit), (EMEA-001032-PIP02-17) in accordance with Regulation

More information

European Medicines Agency decision

European Medicines Agency decision EMA/459054/2017 European Medicines Agency decision P/0208/2017 of 9 August 2017 on the granting of a product specific waiver for H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys- Leu-Ser-Ser-Ile-Glu-Ser-Asp-Val-OH

More information

European Medicines Agency decision

European Medicines Agency decision EMA/86511/2015 European Medicines Agency decision P/0047/2015 of 6 March 2015 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for efinaconazole

More information

Mandate, objectives and rules of procedure

Mandate, objectives and rules of procedure 12 September 2013 Compliance and Inspections Good Clinical Practice Inspectors Working Group (GCP IWG) 1. General considerations In 1997, the Ad Hoc Meeting of GCP Inspection Services was established by

More information

European Medicines Agency decision

European Medicines Agency decision EMA/528123/2014 European Medicines Agency decision P/0252/2014 of 30 September 2014 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver

More information

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL EUROPEAN COMMISSION Brussels, 18.6.2014 COM(2014) 358 final 2014/0180 (COD) Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EU, EURATOM) No 966/2012 on the

More information

European Medicines Agency decision

European Medicines Agency decision EMA/102436/2018 European Medicines Agency decision P/0070/2018 of 16 March 2018 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

European Medicines Agency decision

European Medicines Agency decision EMA/498686/2017 European Medicines Agency decision P/0252/2017 of 4 September 2017 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver

More information

European Medicines Agency decision

European Medicines Agency decision EMA/479450/2016 European Medicines Agency decision P/0199/2016 of 18 July 2016 on the agreement of a paediatric investigation plan and on the granting of a deferral for andexanet alfa (EMEA-001902-PIP01-15)

More information

UNMIK REGULATION NO. 2003/32 ON THE PROMULGATION OF A LAW ADOPTED BY THE ASSEMBLY OF KOSOVO ON ACCESS TO OFFICIAL DOCUMENTS

UNMIK REGULATION NO. 2003/32 ON THE PROMULGATION OF A LAW ADOPTED BY THE ASSEMBLY OF KOSOVO ON ACCESS TO OFFICIAL DOCUMENTS UNITED NATIONS United Nations Interim Administration Mission in Kosovo UNMIK NATIONS UNIES Mission d Administration Intérimaire des Nations Unies au Kosovo UNMIK/REG/2003/32 6 November 2003 REGULATION

More information

EUROPEAN PARLIAMENT DRAFT OPINION. Committee on Petitions PROVISIONAL. 6 September of the Committee on Petitions

EUROPEAN PARLIAMENT DRAFT OPINION. Committee on Petitions PROVISIONAL. 6 September of the Committee on Petitions EUROPEAN PARLIAMT 1999 Committee on Petitions 2004 PROVISIONAL 6 September 2000 DRAFT OPINION of the Committee on Petitions for the Committee on Citizens' Freedoms and Rights, Justice and Home Affairs

More information

RULES OF PROCEDURE OF THE AS-IF PROGRAMME COMMITTEE FOR DEFENCE RESEARCH

RULES OF PROCEDURE OF THE AS-IF PROGRAMME COMMITTEE FOR DEFENCE RESEARCH RULES OF PROCEDURE OF THE AS-IF PROGRAMME COMMITTEE FOR DEFENCE RESEARCH THE AS-IF PROGRAMME COMMITTEE FOR DEFENCE RESEARCH, In view of the implementation of the Pilot Project and the Preparatory Action

More information

European Medicines Agency decision

European Medicines Agency decision EMA/552272/2017 European Medicines Agency decision P/0264/2017 of 4 September 2017 on the granting of a product specific waiver for daratumumab (Darzalex), (EMEA-002152-PIP02-17) in accordance with Regulation

More information

European Medicines Agency decision

European Medicines Agency decision EMA/781916/2015 European Medicines Agency decision P/0315/2015 of 21 December 2015 on the agreement of a paediatric investigation plan and on the granting of a waiver for ethosuximide (EMEA-001617-PIP01-14)

More information

European Medicines Agency decision

European Medicines Agency decision EMA/579489/2016 European Medicines Agency decision P/0234/2016 of 9 September 2016 on the acceptance of a modification of an agreed paediatric investigation plan for brexpiprazole (EMEA-001185-PIP01-11-M03)

More information

European Medicines Agency decision

European Medicines Agency decision EMA/771133/2017 European Medicines Agency decision P/0397/2017 of 19 December 2017 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver

More information

European Medicines Agency decision

European Medicines Agency decision EMA/215073/2015 European Medicines Agency decision P/0085/2015 of 8 May 2015 on the acceptance of a modification of an agreed paediatric investigation plan for ipilimumab (Yervoy), (EMEA-000117-PIP01-07-M07)

More information

Procedure for the review and revision of European Union herbal monographs and European Union list entries

Procedure for the review and revision of European Union herbal monographs and European Union list entries 1 2 3 19 September 2017 EMA/HMPC/124695/2011 Rev. 2 Committee on Herbal Medicinal Products (HMPC) 4 5 6 Procedure for the review and revision of European Union herbal monographs and European Union list

More information

JUDGMENT OF THE GENERAL COURT (Second Chamber) 7 June 2011 (*)

JUDGMENT OF THE GENERAL COURT (Second Chamber) 7 June 2011 (*) JUDGMENT OF THE GENERAL COURT (Second Chamber) 7 June 2011 (*) (Access to documents Regulation (EC) No 1049/2001 Audit report on the parliamentary assistance allowance Refusal of access Exception relating

More information

COMMISSION DECISION. of setting up the Strategic Forum for Important Projects of Common European Interest

COMMISSION DECISION. of setting up the Strategic Forum for Important Projects of Common European Interest EUROPEAN COMMISSION Brussels, 30.1.2018 C(2018) 475 final COMMISSION DECISION of 30.1.2018 setting up the Strategic Forum for Important Projects of Common European Interest EN EN COMMISSION DECISION of

More information

CMDv/BPG/018. BEST PRACTICE GUIDE for Worksharing. Edition number: 03. Edition date: 16 May Implementation date: 01 January 2010

CMDv/BPG/018. BEST PRACTICE GUIDE for Worksharing. Edition number: 03. Edition date: 16 May Implementation date: 01 January 2010 EMA/CMDv/75429/2009 BEST PRACTICE GUIDE for Worksharing Edition number: 03 Edition date: 16 May 2013 Implementation date: 01 January 2010 CMDv Secretariat: 7 Westferry Circus, Canary Wharf, London, E14

More information

European Medicines Agency decision

European Medicines Agency decision EMA/392211/2014 European Medicines Agency decision P/0195/2014 of 8 August 2014 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

European Medicines Agency decision

European Medicines Agency decision EMA/4029/2017 European Medicines Agency decision P/0370/2016 of 4 January 2017 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

European Medicines Agency decision

European Medicines Agency decision EMA/380528/2016 European Medicines Agency decision P/0159/2016 of 15 June 2016 on the refusal of a modification of an agreed paediatric investigation plan for tafluprost (Taflotan and associated names)

More information

COMMISSION DECISION. of on establishing the European Regulators Group for Audiovisual Media Services

COMMISSION DECISION. of on establishing the European Regulators Group for Audiovisual Media Services EUROPEAN COMMISSION Brussels, 3.2.2014 C(2014) 462 final COMMISSION DECISION of 3.2.2014 on establishing the European Regulators Group for Audiovisual Media Services EN EN COMMISSION DECISION of 3.2.2014

More information

European Medicines Agency decision

European Medicines Agency decision EMA/519929/2014 European Medicines Agency decision P/0255/2014 of 30 September 2014 on the agreement of a paediatric investigation plan and on the granting of a waiver for ibuprofen (sodium dihydrate),

More information

Mandate, objectives and rules of procedure for the Inter- Committee Scientific Advisory Group (SAG) for Oncology

Mandate, objectives and rules of procedure for the Inter- Committee Scientific Advisory Group (SAG) for Oncology 25 April 2014 EMA/742599/2014 Human Medicines Evaluation Division Mandate, objectives and rules of procedure for the Inter- Committee Scientific Advisory 1. Legal basis Article 56(2) of Parliament and

More information

European Medicines Agency decision

European Medicines Agency decision EMA/202139/2010 European Medicines Agency decision P/59/2010 of 29 March 2010 on the granting of a product specific waiver for esomeprazole magnesium/acetylsalisylic acid (EMEA-000682-PIP01-09) in accordance

More information

Memorandum of understanding on working arrangements

Memorandum of understanding on working arrangements 26 January 2012 Memorandum of understanding on working arrangements between the European Medicines Agency and the European Food Safety Authority THE EUROPEAN MEDICINES AGENCY AND THE EUROPEAN FOOD SAFETY

More information

European Medicines Agency decision

European Medicines Agency decision EMA/8530/2012 European Medicines Agency decision P/0040/2012 of 24 February 2012 on the granting of a product specific waiver for recombinant Porcine Factor VIII, B-Domain Deleted (EMEA-000753-PIP01-11)

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 1989L0665 EN 09.01.2008 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE of 21 December 1989 on the

More information

PUBLIC PRIVATE PARTNERSHIPS ACT

PUBLIC PRIVATE PARTNERSHIPS ACT LAWS OF KENYA PUBLIC PRIVATE PARTNERSHIPS ACT NO. 15 OF 2013 Revised Edition 2015 [2013] Published by the National Council for Law Reporting with the Authority of the Attorney-General www.kenyalaw.org

More information

and Article I. PURPOSE

and Article I. PURPOSE STATEMENT OF PROTOCOL BETWEEN THE PUBLIC COMPANY ACCOUNTING OVERSIGHT BOARD OF THE UNITED STATES AND THE IRISH AUDITING AND ACCOUNTING SUPERVISORY AUTHORITY OF IRELAND ON COOPERATION AND THE EXCHANGE OF

More information

Procedure for the review and revision of European Union herbal monographs and European Union list entries

Procedure for the review and revision of European Union herbal monographs and European Union list entries 24 July 2018 EMA/HMPC/124695/2011 Rev. 2 Committee on Herbal Medicinal Products (HMPC) Procedure for the review and revision of European Union herbal monographs and European Union list entries Final Draft

More information

European Medicines Agency decision

European Medicines Agency decision EMA/491022/2012 European Medicines Agency decision P/0175/2012 of 27 July 2012 on the granting of a product specific waiver for tafluprost / timolol (EMEA-001216-PIP01-12) in accordance with Regulation

More information

Arrangements to be applied by the Agency for public access to documents (Consolidated Version)

Arrangements to be applied by the Agency for public access to documents (Consolidated Version) MB Decision n 145 Making the railway system work better for society. ANNEX Arrangements to be applied by the Agency for public access to documents (Consolidated Version) THE MANAGEMENT BOARD OF THE EUROPEAN

More information

Telekom Austria Group Standard Data Processing Agreement

Telekom Austria Group Standard Data Processing Agreement Telekom Austria Group Standard Data Processing Agreement This Agreement is entered into by and between: I. [TAG Company NAME], a company duly established and existing under the laws of [COUNTRY] with its

More information

INVESTIGATION OF ELECTRONIC DATA PROTECTED BY ENCRYPTION ETC DRAFT CODE OF PRACTICE

INVESTIGATION OF ELECTRONIC DATA PROTECTED BY ENCRYPTION ETC DRAFT CODE OF PRACTICE INVESTIGATION OF ELECTRONIC DATA PROTECTED BY ENCRYPTION ETC CODE OF PRACTICE Preliminary draft code: This document is circulated by the Home Office in advance of enactment of the RIP Bill as an indication

More information

European Medicines Agency decision

European Medicines Agency decision EMA/683319/2010 European Medicines Agency decision P/307/2010 of 22 December 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

RULES OF PROCEDURE. The Scientific Committees on. Consumer Safety (SCCS) Health and Environmental Risks (SCHER)

RULES OF PROCEDURE. The Scientific Committees on. Consumer Safety (SCCS) Health and Environmental Risks (SCHER) RULES OF PROCEDURE The Scientific Committees on Consumer Safety (SCCS) Health and Environmental Risks (SCHER) Emerging and Newly Identified Health Risks (SCENIHR) APRIL 2013 1 TABLE OF CONTENTS I. INTRODUCTION

More information

European Medicines Agency decision

European Medicines Agency decision EMA/651431/2010 European Medicines Agency decision P/197/2010 of 26 October 2010 on the granting of a product specific waiver for lidocaine hydrochloride, phenylephrine hydrochloride and tropicamide (EMEA-000991-PIP01-10)

More information

BERMUDA 2004 : 32 OMBUDSMAN ACT 2004

BERMUDA 2004 : 32 OMBUDSMAN ACT 2004 BERMUDA 2004 : 32 OMBUDSMAN ACT 2004 Date of Assent: 17 December 2004 Operative Date: 1 May 2005 1 Short title 2 Interpretation 3 Application of the Act 4 Office of Ombudsman 5 Functions and jurisdiction

More information

European Medicines Agency decision

European Medicines Agency decision EMA/802207/2012 European Medicines Agency decision P/0297/2012 of 18 December 2012 on the granting of a product specific waiver for elagolix (EMEA-001323-PIP02-12) in accordance with Regulation (EC) No

More information

Procedure for the systematic review of European Union herbal monographs and/or European Union list entries and supporting documents

Procedure for the systematic review of European Union herbal monographs and/or European Union list entries and supporting documents 28 January 2015 EMA/HMPC/124695/2011 Committee on Herbal Medicinal Products (HMPC) Procedure for the systematic review of European Union herbal monographs and/or European Union list entries and supporting

More information

European Medicines Agency decision

European Medicines Agency decision EMA/249209/2010 European Medicines Agency decision P/75/2010 of 5 May 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for levonorgestrel

More information

PROFESSOR GERALD STEINBERG 1 Ben-Maimon Boulevard, Jerusalem, 92262, Israel Applicant. - and -

PROFESSOR GERALD STEINBERG 1 Ben-Maimon Boulevard, Jerusalem, 92262, Israel Applicant. - and - 1 IN THE GENERAL COURT OF THE COURT OF JUSTICE OF THE EUROPEAN UNION APPLICATION NO. BETWEEN: PROFESSOR GERALD STEINBERG 1 Ben-Maimon Boulevard, Jerusalem, 92262, Israel Applicant - and - THE EUROPEAN

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 1992L0013 EN 09.01.2008 004.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE 92/13/EEC of 25 February 1992

More information

Parallel Consultations

Parallel Consultations Parallel Consultations An overview of the procedure Presented by Jane Moseley on Senior Scientific Officer Scientific Advice Office An agency of the European Union Outline Parallel advice with HTAs Rationale

More information

DECISION OF THE MANAGEMENT BOARD

DECISION OF THE MANAGEMENT BOARD ESMA/2014/MB/60 DECISION OF THE MANAGEMENT BOARD Adopting a Policy on Independence and Decision Making Processes for avoiding Conflicts of Interest (Conflict of Interest Policy) for Non-Staff The Management

More information

COMMISSION DECISION. of

COMMISSION DECISION. of EUROPEAN COMMISSION Brussels, 27.7.2018 C(2018) 4908 final COMMISSION DECISION of 27.7.2018 setting up the group of experts on maritime transport sustainability - The European Sustainable Shipping Forum

More information

EURASIAN ECONOMIC COMMISSION COUNCIL D E C I S I O N. 20 June St. Petersburg

EURASIAN ECONOMIC COMMISSION COUNCIL D E C I S I O N. 20 June St. Petersburg EURASIAN ECONOMIC COMMISSION COUNCIL D E C I S I O N 20 June 2012 48 St. Petersburg On Regulation on the Procedure for Development, Adoption, Amendment and Cancellation of Technical Regulation of the Customs

More information

European Medicines Agency Inspections

European Medicines Agency Inspections European Medicines Agency Inspections London, 27 July 2007 Doc. Ref.: EMEA/INS/GCP/239486/2007 MANDATE, OBJECTIVES AND RULES OF PROCEDURE FOR THE GCP INSPECTORS WORKING GROUP (GCP IWG) I. GENERAL CONSIDERATIONS

More information

Official Journal of the European Union L 251/3

Official Journal of the European Union L 251/3 24.9.2009 Official Journal of the European Union L 251/3 COMMISSION REGULATION (EC) No 874/2009 of 17 September 2009 establishing implementing rules for the application of Council Regulation (EC) No 2100/94

More information

European Medicines Agency decision

European Medicines Agency decision EMA/670696/2010 European Medicines Agency decision P/259/2010 of 26 November 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

European Medicines Agency decision

European Medicines Agency decision EMA/802406/2010 European Medicines Agency decision P/289/2010 of 22 December 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

"Body" means a governmental, international or non-profit organisation. ***

Body means a governmental, international or non-profit organisation. *** Declaration of interests (DOI) form for individuals applying to be appointed as members of the Strategic Forum for Important Projects of Common European Interest in a personal capacity Legal basis: Commission

More information

9308/16 JT/CSM/nb 1 DG F 2C

9308/16 JT/CSM/nb 1 DG F 2C Council of the European Union Brussels, 10 June 2016 (OR. en) 9308/16 INF 86 API 59 'I/A' ITEM NOTE From: To: No. prev. doc.: 8942/16 Subject: Working Party on Information Permanent Representatives Committee/Council

More information

(12) Environmental information which is physically held by other bodies on behalf of public authorities should also fall within the scope of this

(12) Environmental information which is physically held by other bodies on behalf of public authorities should also fall within the scope of this Directive 2003/4/EC of the European Parliament and of the Council of 28 January 2003 on public access to environmental information and repealing Council Directive 90/313/EEC Official Journal L 041, 14/02/2003

More information

Title: Handling of Paediatric Art. 45 work sharing procedures by the CMDh Secretariat

Title: Handling of Paediatric Art. 45 work sharing procedures by the CMDh Secretariat Work instructions Title: Handling of Paediatric Art. 45 work sharing procedures by the CMDh Secretariat Applies to: CMDh secretariat within Committees Secretariat in the Scientific Committee Support Department

More information

ANNEX RELATIONS WITH THE COMPLAINANT REGARDING INFRINGEMENTS OF EU LAW

ANNEX RELATIONS WITH THE COMPLAINANT REGARDING INFRINGEMENTS OF EU LAW Commission Communication to the European Parliament and the European Ombudsman on relations with the complainant in respect of infringements of European Union (EU) law ANNEX Deleted: COMMUNITY RELATIONS

More information

THE FREEDOM OF INFORMATION ACT, Arrangement of Sections PART I PRELIMINARY

THE FREEDOM OF INFORMATION ACT, Arrangement of Sections PART I PRELIMINARY THE FREEDOM OF INFORMATION ACT, 1999 Section 1. Short title 2. Commencement 3. Object of Act 4. Interpretation 5. Non-application of Act 6. Act binds the State Arrangement of Sections PART I PRELIMINARY

More information

European Medicines Agency decision

European Medicines Agency decision EMA/683356/2010 European Medicines Agency decision P/271/2010 of 3 December 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

GRANT AGREEMENT for an ACTION

GRANT AGREEMENT for an ACTION Directorate General Communication GRANT AGREEMENT for an ACTION AGREEMENT NUMBER - [ ] The European Community, represented for the purposes of the signature of this agreement by the European Parliament,

More information

Act No. 502 of 23 May 2018

Act No. 502 of 23 May 2018 Act No. 502 of 23 May 2018 This version has been translated for the Danish Ministry of Justice. The official version was published in Lovtidende (the Law Gazette) on 24 May 2018. Only the Danish version

More information

ARTICLE 29 Data Protection Working Party

ARTICLE 29 Data Protection Working Party ARTICLE 29 Data Protection Working Party 11580/03/EN WP 82 Opinion 6/2003 on the level of protection of personal data in the Isle of Man Adopted on 21 November 2003 This Working Party was set up under

More information

COMMISSION OPINION. of

COMMISSION OPINION. of EUROPEAN COMMISSION Brussels, 5.5.2014 C(2014) 3066 final COMMISSION OPINION of 5.5.2014 Opinion of the European Commission in application of Article 15(1) of Council Regulation (EC) 1/2003 of 16 December

More information

OUTCOME OF THE COUNCIL MEETING. 3542nd Council meeting. General Affairs. (Art. 50) Brussels, 22 May 2017 PRESS

OUTCOME OF THE COUNCIL MEETING. 3542nd Council meeting. General Affairs. (Art. 50) Brussels, 22 May 2017 PRESS Council of the European Union 9569/17 (OR. en) PRESSE 29 PR CO 29 OUTCOME OF THE COUNCIL MEETING 3542nd Council meeting General Affairs (Art. 50) Brussels, 22 May 2017 President Louis Grech Deputy Prime

More information

S.I. 7 of 2014 PUBLIC PROCUREMENT ACT. (Act No. 33 of 2008) PUBLIC PROCUREMENT REGULATIONS, 2014 ARRANGEMENTS OF REGULATIONS PART 1 - PRELIMINARY

S.I. 7 of 2014 PUBLIC PROCUREMENT ACT. (Act No. 33 of 2008) PUBLIC PROCUREMENT REGULATIONS, 2014 ARRANGEMENTS OF REGULATIONS PART 1 - PRELIMINARY [27th January 2014] Supplement to Official Gazette 939 S.I. 7 of 2014 PUBLIC PROCUREMENT ACT (Act No. 33 of 2008) PUBLIC PROCUREMENT REGULATIONS, 2014 ARRANGEMENTS OF REGULATIONS PART 1 - PRELIMINARY 1.

More information

COMPLAINTS AND APPEALS POLICY & PROCEDURE

COMPLAINTS AND APPEALS POLICY & PROCEDURE COMPLAINTS AND APPEALS POLICY & PROCEDURE General Complaints Where possible all non-formal attempts shall be made to resolve the issue. This may include advice, discussions, and general mediation in relation

More information

Official Journal of the European Union L 131/7. COUNCIL DECISION of 14 May 2008 establishing a European Migration Network (2008/381/EC)

Official Journal of the European Union L 131/7. COUNCIL DECISION of 14 May 2008 establishing a European Migration Network (2008/381/EC) 21.5.2008 Official Journal of the European Union L 131/7 COUNCIL DECISION of 14 May 2008 establishing a European Migration Network (2008/381/EC) THE COUNCIL OF THE EUROPEAN UNION, Reinforcing the collection,

More information

European Medicines Agency decision

European Medicines Agency decision EMA/58370/2014 European Medicines Agency decision P/0047/2014 of 11 March 2014 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for

More information

Terms of Reference and Rules of Procedure Health Products Regulatory Authority

Terms of Reference and Rules of Procedure Health Products Regulatory Authority Terms of Reference and Rules of Procedure Health Products Regulatory Authority MGT-P0007-16 7 JUNE 2018 CONTENTS 1 ESTABLISHMENT 3 2 MANDATE 3 3 COMPOSITION 6 4 CHAIRPERSON 6 5 SECRETARY TO THE AUTHORITY

More information

ARTICLE 29 DATA PROTECTION WORKING PARTY

ARTICLE 29 DATA PROTECTION WORKING PARTY ARTICLE 29 DATA PROTECTION WORKING PARTY 18/EN WP 257 rev.01 Working Document setting up a table with the elements and principles to be found in Processor Binding Corporate Rules Adopted on 28 November

More information

BERMUDA COPYRIGHT TRIBUNAL RULES 2014 BR 11 / 2014

BERMUDA COPYRIGHT TRIBUNAL RULES 2014 BR 11 / 2014 QUO FA T A F U E R N T BERMUDA COPYRIGHT TRIBUNAL RULES 2014 BR 11 / 2014 TABLE OF CONTENTS 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 PART 1 PRELIMINARY Citation Interpretation Overriding objective Tribunal

More information

Council Regulation (EC) No 2532/98 (23 November 1998)

Council Regulation (EC) No 2532/98 (23 November 1998) Council Regulation (EC) No 2532/98 (23 November 1998) Caption: Council Regulation (EC) No 2532/98 of 23 November 1998 concerning the powers of the European Central Bank to impose sanctions. Source: Official

More information

German construction contract procedures (VOB) - Part A: General provisions relating to the award of construction contracts

German construction contract procedures (VOB) - Part A: General provisions relating to the award of construction contracts DIN 1960:2016-09 (E) German construction contract procedures (VOB) - Part A: General provisions relating to the award of construction contracts Contents Page Foreword 6 German construction contract procedures

More information

EUROPEAN COMMISSION. Brussels, BY AND REGISTERED MAIL WITH ACKNOWLEDGEMENT OF RECEIPT

EUROPEAN COMMISSION. Brussels, BY  AND REGISTERED MAIL WITH ACKNOWLEDGEMENT OF RECEIPT Ref. Ares(2016)5412776-16/09/2016 EUROPEAN COMMISSION LEGAL SERVICE The Director General Brussels, Mrs Lena Blanken foodwatch e.v. Brunnenstr. 181 10119 Berlin Germany lena.blanken@foodwatch.de BY E-MAIL

More information

Data Protection Bill [HL]

Data Protection Bill [HL] [AS AMENDED IN COMMITTEE] CONTENTS PART 1 PRELIMINARY 1 Overview 2 Terms relating to the processing of personal data PART 2 GENERAL PROCESSING CHAPTER 1 SCOPE AND DEFINITIONS 3 Processing to which this

More information

The court may allow a witness to give evidence through a video link or by other

The court may allow a witness to give evidence through a video link or by other PART 8 : CHAPTER 1: EVIDENCE GENERAL 8.1 Power of court to control evidence (32.1) (1) The court may control the evidence by giving directions as to (c) the issues on which it requires evidence; the nature

More information

European Medicines Agency decision

European Medicines Agency decision EMA/475432/2012 European Medicines Agency decision P/0163/2012 of 23 July 2012 on the agreement of a paediatric investigation plan and on the granting of a waiver for misoprostol (EMEA-001159-PIP02-12)

More information

Development of a European approach to assess the fire performance of facades

Development of a European approach to assess the fire performance of facades EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Industrial Transformation and Advanced Value Chains Brussels, 13/07/2016 grow.ddg1.c.dir(2016)3448477 Dear

More information

Proposal for a COUNCIL DECISION

Proposal for a COUNCIL DECISION EUROPEAN COMMISSION Brussels, 14.2.2018 COM(2018) 71 final 2018/0032 (NLE) Proposal for a COUNCIL DECISION on the conclusion, on behalf of the European Union, of an Agreement between the European Union

More information